Market Analysis:
North America Drug Delivery Market is expected to reach USD 501.4 billion in 2016 and is projected to reach USD 814.4 billion by 2024, at a CAGR of 6.4% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Some of the major factors driving the market for North America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.
Key Points: North America Drug Delivery Market
• Johnson & Johnson Services, Inc.,
• Novartis AG
• F. Hoffmann-La Roche AG,
• Pfizer, Inc.,
• GlaxoSmithKline plc. ,
• Merck & Co.,
• Sanofi,
• Antares Pharma,
• 3M,
• Becton Dickinson and Company,
• Nemera, Cima Labs, Inc.,
• Dali Medical Devices,
• Alkermes,
• Foamis,
• Ypsomed,
• Skyepharma AG,
• Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc
• Injectable Drug Delivery market is growing with the highest CAGR.
• Globally solid oral is driving the market with highest market share along with highest CAGR.
• Tabletis dominating the North America solid oral drug delivery market.
Get Free Report Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=north-america-drug-delivery-market-2
By Route of Administration
Oral
• Solid,
• Liquid,
• Semi-Solid
Injectable,
• Topical
• Formulations,
• Transdermal Devices
Pulmonary
• MDI,
• DPI,
• Nebulizers
• Nasal,
• Ocular,
• Implantable,
• Transmucosal
By End-User
• Hospitals,
• Clinics,
• Home Healthcare,
• Community Centers,
By Distribution Channel
• Direct Tenders,
• Hospital Pharmacies,
• Pharmacy Stores,
• Online Pharmacies
By Country
• U.S.,
• Canada,
• Mexico
Market Segmentation: North America Drug Delivery
• On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. The Injectable drug delivery segment is further segmented into devices and formulations.
• The devices segment is categorized as conventional injections, self-injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. In 2017, on the basis of route of administration, oral drug delivery market is expected to dominate the market with 41.0% market share.
• The Pulmonary Drug Delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
• Ocular drug delivery is segmented into liquid ocular drugs, semi-solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
Key Drivers: North America Drug Delivery Market
Some of the major factors driving the market for North America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.

• An opportunity for the pharmaceutical companies to focus on introducing various products in the market.
• Significant growth in the biologics market due to the increased spending by the pharmaceutical companies on biologics.
• The development of new drug delivery systems administration of drugs through different routes becomes more efficient and effective.
Read Full TOC with Tables at @ https://databridgemarketresearch.com/toc/?dbmr=north-america-drug-delivery-market-2

Read more about this Report @ https://databridgemarketresearch.com/news/product-launch/north-america-drug-delivery-market-2/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]